Histidine

Histidine

SCHEMBL3194028

N[C@@H](CC(=O)O)C(=O)O.N[C@@H](Cc1c[nH]cn1)C(=O)O.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SSTR1SSTR2SSTR3SSTR5

The experimentally established mechanism targets of Histidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.32
SLC7A5 Q01650 1/20 0.32
CTSC P53634 1/20 0.31
CYP1A2 P05177 1/20 0.31
ITGB3 P05106 1/20 0.30
ITGAV P06756 1/20 0.30
ITGA2B P08514 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Histidine SCHEMBL2586200 0.94 SLC7A5 (0.35) CYP3A4SLC7A5CTSCCYP1A2
D-Histidine SCHEMBL11606906 0.94 SLC7A5 (0.35) CYP3A4SLC7A5CTSCCYP1A2
Histidine SCHEMBL27902238 0.94 SLC7A5 (0.35) CYP3A4SLC7A5CTSCCYP1A2
Histidine SCHEMBL2586203 0.94 SLC7A5 (0.35) CYP3A4SLC7A5CTSCCYP1A2
Histidine SCHEMBL5583260 0.93 CYP3A4 (0.31) CYP3A4SLC7A5CTSCCYP1A2
Histidine SCHEMBL3490081 0.93 CYP3A4 (0.32) CYP3A4SLC7A5CTSCCYP1A2
Histidine SCHEMBL3088582 0.93 CYP3A4 (0.32) CYP3A4SLC7A5CTSCCYP1A2
Histidine SCHEMBL1675273 0.93 CYP3A4 (0.32) CYP3A4SLC7A5CTSCCYP1A2
Histidine SCHEMBL790243 0.93 CYP3A4 (0.32) CYP3A4SLC7A5CTSCCYP1A2
Histidine SCHEMBL790244 0.93 CYP3A4 (0.32) CYP3A4SLC7A5CTSCCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180187269-A1 COMPOSITIONS, METHODS AND KITS FOR THE DIAGNOSIS OF CARRIERS OF MUTATIONS IN THE BRCA1 AND BRCA2 GENES AND EARLY DIAGNOSIS OF CANCEROUS DISORDERS ASSOCIATED WITH MUTATIONS IN BRCA1 AND BRCA2 GENES HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED (IL) 2018-07-05 US disclosed
US-20150354014-A1 Compositions, methods and kits for diagnosis of carriers of mutations in the BRCA1 and BRCA2 genes and early diagnosis of cancerous disorders associated with mutations in BRCA1 and BRCA 2 genes HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED (IL) 2015-12-10 US disclosed
US-20100267569-A1 Compositions, methods and kits for the diagnosis of carriers of mutations in the BRCA1 and BRCA2 genes and early diagnosis of cancerous disorders associated with mutations in BRCA1 and BRCA2 genes HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (IL) 2010-10-21 US disclosed
EP-2176424-A2 COMPOSITIONS, METHODS AND KITS FOR THE DIAGNOSIS OF CARRIERS OF MUTATIONS IN THE BRCA1 AND BRCA2 GENES AND EARLY DIAGNOSIS OF CANCEROUS DISORDERS ASSOCIATED WITH MUTATIONS IN BRCA1 AND BRCA2 GENES Hadasit Medical Research Services & Development Ltd. (IL) 2010-04-21 EP disclosed
US-7667099-B2 Plastid division and related genes and proteins, and methods of use BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2010-02-23 US disclosed
WO-2009007958-A2 COMPOSITIONS, METHODS AND KITS FOR THE DIAGNOSIS OF CARRIERS OF MUTATIONS IN THE BRCA1 AND BRCA2 GENES AND EARLY DIAGNOSIS OF CANCEROUS DISORDERS ASSOCIATED WITH MUTATIONS IN BRCA1 AND BRCA2 GENES HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. (IL) 2009-01-15 WO disclosed
US-20040139500-A1 Plastid division and related genes and proteins, and methods of use THE BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY 2004-07-15 US disclosed
WO-2004001003-A2 PLASTID DIVISION AND RELATED GENES AND PROTEINS, AND METHODS OF USE BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) 2003-12-31 WO disclosed